- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | 4D Pharma reveals progress in phase 2 trial of live biotherapeutic candidate in bladder cancer | ||
| Fr | Merck KGaA launches largest single investment in manufacturing | ||
| Fr | Hanmi expands offerings with 'high-tech' CDMO services | ||
| Mi | Inceptor Bio generates $37m in funding round as it advances CAR-T platform into the clinic | ||
| Mi | Lithuanian CDMO to open facility in Boston | ||
| Di | Lonza to lend manufacturing expertise and knowledge to Israeli biotechs | ||
| Mo | Lonza houses bioconjugation facility for Kodiak | ||
| Mo | BD and Mitsubishi partner to create 'next-gen' syringe | ||
| 19.05. | Can Sernova and Evotec's cell therapy approach result in a functional cure for diabetes? | ||
| 19.05. | WHO validates 11th COVID-19 vaccine | ||
| 19.05. | Bacteriophage producer Locus Biosciences raises $35m in financing | ||
| 19.05. | AGC Biologics adds new viral vector suspension capabilities at US cell & gene facility | ||
| 17.05. | Korea's Lotte plans to scale its biologics CDMO business in North America as it buys BMS site | ||
| 17.05. | AbbVie and Cugene ink autoimmune therapy partnership | ||
| 17.05. | RQ Bio launches to develop therapies based on broad-spectrum mAbs | ||
| 17.05. | BeiGene opens regional office in Basel to strengthen European presence | ||
| 16.05. | Survey puts spotlight on US neurologists' response to CMS Alzheimer drugs decision | ||
| 16.05. | Novartis looks to work more strategically as CDMO | ||
| 16.05. | EU sets out intention to terminate COVID-19 vaccine deal with Valneva | ||
| 16.05. | Gerresheimer ramps up glass and plastic production capacities in India | ||
| 12.05. | Lonza secures deal with ALSA Ventures to support its portfolio of biotechs | ||
| 12.05. | What are the benefits of oral delivery of insulin and how can algae support candidate therapeutic proteins? | ||
| 12.05. | Bora Pharmaceuticals acquires Eden Biologics, as it continues to expand its CDMO focus | ||
| 12.05. | What are the benefits or oral delivery of insulin and how can algae support candidate therapeutic proteins? | ||
| 10.05. | FDA outlines benefit-risk approach to drug or biologic product quality assessment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
